International
Hims to Stop Offering GLP-1 Pill After FDA Warned of Crackdown
UNITED STATES – Online telehealth company Hims & Hers is backing off plans to sell a 49-dollar compounded version of Novo Nordisk’s weight-loss drug Wegovy after warning signs from federal regulators.
-
National2 days agoConvicted Armed Robber Faces New Drug Charge In Prison
-
Regional2 days agoCaribbean Loses $2 Billion Annually Due to Climate Change
-
International2 days agoEuropean Countries Battle Wildfires Across the Region
-
National2 days agoManagers Union Pushes Back Against Overtime Backlash
-
Sports2 days agoBahamian Players Set for Head-to-head Matchups
-
National2 days agoOWN Bahamas Pours Into the Next Generation of Entrepreneurs
-
Entertainment1 day agoMannie Fresh Set to Make Debut at Jon Batiste’s Jazz Club
-
National2 days agoBuilding the Legacy – CBL Leadership Dev. Program



